Clinical Research Network on Antimicrobial Resistance

The National Institutes of Health (NIH) is offering a cooperative agreement opportunity titled "Clinical Research Network on Antimicrobial Resistance" aimed at advancing research on antimicrobial resistance (AMR). This initiative seeks to design, implement, and manage clinical research that addresses critical questions related to AMR, particularly focusing on bacterial and fungal infections, the clinical testing of new antibiotics, and the evaluation of novel diagnostic tests. The program is crucial for addressing a significant health challenge that affects vulnerable populations, such as individuals with chronic conditions, and aims to reduce healthcare costs associated with resistant infections. The estimated total funding for this program is $15 million, with one award expected to be granted. Interested applicants can reach out to the Division of Microbiology and Infectious Diseases via email at AMRClinicalResearchNetworkContact@mail.nih.gov, with key deadlines including an estimated synopsis close date of September 29, 2026, and an anticipated project start date of July 1, 2027.